{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T16:09:39Z","timestamp":1779466179178,"version":"3.53.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200673"],"award-info":[{"award-number":["82200673"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"DOI":"10.1007\/s12072-026-11100-9","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T16:00:42Z","timestamp":1779465642000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Machine learning outperforms serum creatinine for early risk stratification of hepatorenal syndrome: a prospective single-center validation"],"prefix":"10.1007","author":[{"given":"Yuli","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixiao","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengchen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0766-8794","authenticated-orcid":false,"given":"Chengbo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"issue":"1","key":"11100_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-018-0022-7","volume":"4","author":"P Gin\u00e8s","year":"2018","unstructured":"Gin\u00e8s P, Sol\u00e0 E, Angeli P, Wong F, Nadim MK, Kamath PS. Hepatorenal syndrome. Nat Rev Dis Primers. 2018;4(1):1\u201317. https:\/\/doi.org\/10.1038\/s41572-018-0022-7","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"11100_CR2","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/j.kint.2021.02.037","volume":"99","author":"G Eknoyan","year":"2021","unstructured":"Eknoyan G, Epstein M. Hepatorenal syndrome: a historical appraisal of its origins and conceptual evolution. Kidney Int. 2021;99(6):1321\u20131330. https:\/\/doi.org\/10.1016\/j.kint.2021.02.037","journal-title":"Kidney Int"},{"issue":"4","key":"11100_CR3","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1053\/j.gastro.2023.11.306","volume":"166","author":"E Pose","year":"2024","unstructured":"Pose E, Piano S, Juanola A, Gin\u00e8s P. Hepatorenal syndrome in cirrhosis. Gastroenterology. 2024;166(4):588\u2013604. https:\/\/doi.org\/10.1053\/j.gastro.2023.11.306","journal-title":"Gastroenterology"},{"issue":"6","key":"11100_CR4","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1016\/j.jhep.2023.07.010","volume":"79","author":"KR Patidar","year":"2023","unstructured":"Patidar KR, Belcher JM, Regner KR, et al. Incidence and outcomes of acute kidney injury including hepatorenal syndrome in hospitalized patients with cirrhosis in the US. J Hepatol. 2023;79(6):1408\u20131417. https:\/\/doi.org\/10.1016\/j.jhep.2023.07.010","journal-title":"J Hepatol"},{"issue":"10","key":"11100_CR5","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1111\/apt.17232","volume":"56","author":"AK Singal","year":"2022","unstructured":"Singal AK, Kuo YF, Reddy KR, Bataller R, Kwo P. Healthcare burden and outcomes of hepatorenal syndrome among cirrhosis-related hospitalisations in the US. Aliment Pharmacol Ther. 2022;56(10):1486\u20131496. https:\/\/doi.org\/10.1111\/apt.17232","journal-title":"Aliment Pharmacol Ther"},{"key":"11100_CR6","doi-asserted-by":"publisher","unstructured":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the global burden of disease study 2019. Lancet 2020;396(10258):1204\u20131222. https:\/\/doi.org\/10.1016\/S0140-6736(20)30925-9","DOI":"10.1016\/S0140-6736(20)30925-9"},{"issue":"3","key":"11100_CR7","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41581-019-0218-4","volume":"16","author":"JCQ Velez","year":"2020","unstructured":"Velez JCQ, Therapondos G, Juncos LA. Reappraising the spectrum of AKI and hepatorenal syndrome in patients with cirrhosis. Nat Rev Nephrol. 2020;16(3):137\u2013155. https:\/\/doi.org\/10.1038\/s41581-019-0218-4","journal-title":"Nat Rev Nephrol"},{"issue":"4","key":"11100_CR8","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.jhep.2014.12.029","volume":"62","author":"P Angeli","year":"2015","unstructured":"Angeli P, Gin\u00e8s P, Wong F, et al. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites. J Hepatol. 2015;62(4):968\u2013974. https:\/\/doi.org\/10.1016\/j.jhep.2014.12.029","journal-title":"J Hepatol"},{"issue":"1","key":"11100_CR9","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jhep.2024.03.031","volume":"81","author":"MK Nadim","year":"2024","unstructured":"Nadim MK, Kellum JA, Forni L, et al. Acute kidney injury in patients with cirrhosis: acute disease quality initiative (ADQI) and International Club of Ascites (ICA) joint multidisciplinary consensus meeting. J Hepatol. 2024;81(1):163\u2013183. https:\/\/doi.org\/10.1016\/j.jhep.2024.03.031","journal-title":"J Hepatol"},{"issue":"8","key":"11100_CR10","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1111\/apt.70265","volume":"62","author":"J Ma","year":"2025","unstructured":"Ma J, Chen X, Zhou Q, et al. MELD 3.0 improves risk stratification and mortality prediction in hepatorenal syndrome-acute kidney injury: a multicentre study. Aliment Pharmacol Ther. 2025;62(8):821\u2013832. https:\/\/doi.org\/10.1111\/apt.70265","journal-title":"Aliment Pharmacol Ther"},{"key":"11100_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13600","author":"R Maiwall","year":"2018","unstructured":"Maiwall R, Kumar A, Bhardwaj A, Kumar G, Bhadoria AS, Sarin SK. Cystatin C predicts acute kidney injury and mortality in cirrhotics: a prospective cohort study. Liver Int Off J Int Assoc Study Liver. 2018. https:\/\/doi.org\/10.1111\/liv.13600","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"issue":"2","key":"11100_CR12","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.jhep.2012.03.015","volume":"57","author":"C Fagundes","year":"2012","unstructured":"Fagundes C, P\u00e9pin MN, Guevara M, et al. Urinary neutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis. J Hepatol. 2012;57(2):267\u2013273. https:\/\/doi.org\/10.1016\/j.jhep.2012.03.015","journal-title":"J Hepatol"},{"issue":"2","key":"11100_CR13","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/hep.26980","volume":"60","author":"JM Belcher","year":"2014","unstructured":"Belcher JM, Sanyal AJ, Peixoto AJ, et al. Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury. Hepatology. 2014;60(2):622\u2013632. https:\/\/doi.org\/10.1002\/hep.26980","journal-title":"Hepatology"},{"issue":"6","key":"11100_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0128145","volume":"10","author":"X Ariza","year":"2015","unstructured":"Ariza X, Sol\u00e0 E, Elia C, et al. Analysis of a urinary biomarker panel for clinical outcomes assessment in cirrhosis. PLoS ONE. 2015;10(6): e0128145. https:\/\/doi.org\/10.1371\/journal.pone.0128145","journal-title":"PLoS ONE"},{"issue":"7","key":"11100_CR15","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.cgh.2016.11.035","volume":"15","author":"J Puthumana","year":"2017","unstructured":"Puthumana J, Ariza X, Belcher JM, Graupera I, Gin\u00e8s P, Parikh CR. Urine interleukin 18 and lipocalin 2 are biomarkers of acute tubular necrosis in patients with cirrhosis: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2017;15(7):1003-1013.e3. https:\/\/doi.org\/10.1016\/j.cgh.2016.11.035","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"11100_CR16","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1002\/hep.29290","volume":"66","author":"D Markwardt","year":"2017","unstructured":"Markwardt D, Holdt L, Steib C, et al. Plasma cystatin C is a predictor of renal dysfunction, acute-on-chronic liver failure, and mortality in patients with acutely decompensated liver cirrhosis. Hepatology Baltimore Md. 2017;66(4):1232\u20131241. https:\/\/doi.org\/10.1002\/hep.29290","journal-title":"Hepatology Baltimore Md"},{"issue":"1","key":"11100_CR17","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1136\/gutjnl-2023-329923","volume":"73","author":"A Juanola","year":"2023","unstructured":"Juanola A, Ma AT, de Wit K, et al. Novel prognostic biomarkers in decompensated cirrhosis: a systematic review and meta-analysis. Gut. 2023;73(1):156\u2013165. https:\/\/doi.org\/10.1136\/gutjnl-2023-329923","journal-title":"Gut"},{"issue":"9","key":"11100_CR18","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1136\/gutjnl-2021-326271","volume":"71","author":"E Uche-Anya","year":"2022","unstructured":"Uche-Anya E, Anyane-Yeboa A, Berzin TM, Ghassemi M, May FP. Artificial intelligence in gastroenterology and hepatology: how to advance clinical practice while ensuring health equity. Gut. 2022;71(9):1909\u20131915. https:\/\/doi.org\/10.1136\/gutjnl-2021-326271","journal-title":"Gut"},{"issue":"6","key":"11100_CR19","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/j.jhep.2022.01.014","volume":"76","author":"J Calderaro","year":"2022","unstructured":"Calderaro J, Seraphin TP, Luedde T, Simon TG. Artificial intelligence for the prevention and clinical management of hepatocellular carcinoma. J Hepatol. 2022;76(6):1348\u20131361. https:\/\/doi.org\/10.1016\/j.jhep.2022.01.014","journal-title":"J Hepatol"},{"issue":"6","key":"11100_CR20","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/j.jhep.2023.01.006","volume":"78","author":"M Bhat","year":"2023","unstructured":"Bhat M, Rabindranath M, Chara BS, Simonetto DA. Artificial intelligence, machine learning, and deep learning in liver transplantation. J Hepatol. 2023;78(6):1216\u20131233. https:\/\/doi.org\/10.1016\/j.jhep.2023.01.006","journal-title":"J Hepatol"},{"issue":"8","key":"11100_CR21","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41575-024-00919-y","volume":"21","author":"J Calderaro","year":"2024","unstructured":"Calderaro J, \u017digutyt\u0117 L, Truhn D, Jaffe A, Kather JN. Artificial intelligence in liver cancer - new tools for research and patient management. Nat Rev Gastroenterol Hepatol. 2024;21(8):585\u2013599. https:\/\/doi.org\/10.1038\/s41575-024-00919-y","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"11100_CR22","doi-asserted-by":"publisher","DOI":"10.19871\/j.cnki.xfcrbzz.2025.03.004","author":"W Bao","year":"2025","unstructured":"Bao W, Zhang L, Hua P, Wang Z. Construction and validation of an early prediction model for hepatorenal syndrome in patients with decompensated hepatitis B cirrhosis. J Clin Exp Hepatol. 2025. https:\/\/doi.org\/10.19871\/j.cnki.xfcrbzz.2025.03.004. (Published online: 5 Aug 2025, Accessed: 22 Oct)","journal-title":"J Clin Exp Hepatol"},{"issue":"28","key":"11100_CR23","doi-asserted-by":"publisher","first-page":"9688","DOI":"10.1021\/acs.analchem.1c00578","volume":"93","author":"RC Spiers","year":"2021","unstructured":"Spiers RC, Kalivas JH. Calibration model updating to novel sample and measurement conditions without reference values. Anal Chem. 2021;93(28):9688\u20139696. https:\/\/doi.org\/10.1021\/acs.analchem.1c00578","journal-title":"Anal Chem"},{"issue":"5","key":"11100_CR24","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1002\/hep.30932","volume":"71","author":"SK Asrani","year":"2020","unstructured":"Asrani SK, Jennings LW, Kim WR, et al. MELD-GRAIL-Na: glomerular filtration rate and mortality on liver-transplant waiting list. Hepatology. 2020;71(5):1766\u20131774. https:\/\/doi.org\/10.1002\/hep.30932","journal-title":"Hepatology"},{"issue":"3","key":"11100_CR25","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.jhep.2024.03.006","volume":"81","author":"AT Ma","year":"2024","unstructured":"Ma AT, Sol\u00e9 C, Juanola A, et al. Prospective validation of the EASL management algorithm for acute kidney injury in cirrhosis. J Hepatol. 2024;81(3):441\u2013450. https:\/\/doi.org\/10.1016\/j.jhep.2024.03.006","journal-title":"J Hepatol"},{"issue":"1","key":"11100_CR26","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41591-018-0316-z","volume":"25","author":"A Esteva","year":"2019","unstructured":"Esteva A, Robicquet A, Ramsundar B, et al. A guide to deep learning in healthcare. Nat Med. 2019;25(1):24\u201329. https:\/\/doi.org\/10.1038\/s41591-018-0316-z","journal-title":"Nat Med"},{"issue":"1","key":"11100_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.7326\/0003-4819-157-1-201207030-00450","volume":"157","author":"TJ Bright","year":"2012","unstructured":"Bright TJ, Wong A, Dhurjati R, et al. Effect of clinical decision-support systems: a systematic review. Ann Intern Med. 2012;157(1):29\u201343. https:\/\/doi.org\/10.7326\/0003-4819-157-1-201207030-00450","journal-title":"Ann Intern Med"},{"issue":"6","key":"11100_CR28","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1177\/0272989X06295361","volume":"26","author":"AJ Vickers","year":"2006","unstructured":"Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making. 2006;26(6):565\u2013574. https:\/\/doi.org\/10.1177\/0272989X06295361","journal-title":"Med Decis Making"},{"issue":"21","key":"11100_CR29","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1001\/jama.2018.17163","volume":"320","author":"EH Shortliffe","year":"2018","unstructured":"Shortliffe EH, Sep\u00falveda MJ. Clinical decision support in the era of artificial intelligence. JAMA. 2018;320(21):2199\u20132200. https:\/\/doi.org\/10.1001\/jama.2018.17163","journal-title":"JAMA"},{"issue":"7","key":"11100_CR30","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1001\/jamasurg.2021.0534","volume":"156","author":"NN Massarweh","year":"2021","unstructured":"Massarweh NN, Haukoos JS, Ghaferi AA. ISPOR reporting guidelines for comparative effectiveness research. JAMA Surg. 2021;156(7):673\u2013674. https:\/\/doi.org\/10.1001\/jamasurg.2021.0534","journal-title":"JAMA Surg"},{"issue":"1","key":"11100_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7326\/M22-1258","volume":"176","author":"S Gulati","year":"2023","unstructured":"Gulati S, Eckman MH. Anticoagulant therapy for cancer-associated thrombosis\u202f: a cost-effectiveness analysis. Ann Intern Med. 2023;176(1):1\u20139. https:\/\/doi.org\/10.7326\/M22-1258","journal-title":"Ann Intern Med"},{"issue":"6","key":"11100_CR32","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s40258-022-00752-x","volume":"20","author":"S Moler-Zapata","year":"2022","unstructured":"Moler-Zapata S, Kreif N, Ochalek J, Mirelman AJ, Nadjib M, Suhrcke M. Estimating the health effects of expansions in health expenditure in Indonesia: a dynamic panel data approach. Appl Health Econ Health Policy. 2022;20(6):881\u2013891. https:\/\/doi.org\/10.1007\/s40258-022-00752-x","journal-title":"Appl Health Econ Health Policy"},{"key":"11100_CR33","doi-asserted-by":"publisher","DOI":"10.7573\/dic.2024-1-1","volume":"13","author":"I Hasan","year":"2024","unstructured":"Hasan I, Murti IS, Bayupurnama P, et al. Cost-effectiveness of albumin in the treatment of decompensated cirrhosis in resource-limited healthcare settings. Drugs Context. 2024;13: 2024-1-1. https:\/\/doi.org\/10.7573\/dic.2024-1-1","journal-title":"Drugs Context"},{"key":"11100_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijnurstu.2024.104779","author":"R Wolff","year":"2024","unstructured":"Wolff R, Heusler A, Kunaschk M, Osiander C. Willingness to pay for improved working conditions of nurses: results from a factorial survey experiment in Germany. Int J Nurs Stud. 2024. https:\/\/doi.org\/10.1016\/j.ijnurstu.2024.104779","journal-title":"Int J Nurs Stud"},{"issue":"3","key":"11100_CR35","doi-asserted-by":"publisher","first-page":"320","DOI":"10.7326\/M22-2216","volume":"176","author":"I Toumazis","year":"2023","unstructured":"Toumazis I, Cao P, de Nijs K, et al. Risk model-based lung cancer screening\u202f: a cost-effectiveness analysis. Ann Intern Med. 2023;176(3):320\u2013332. https:\/\/doi.org\/10.7326\/M22-2216","journal-title":"Ann Intern Med"},{"issue":"5","key":"11100_CR36","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1111\/all.16537","volume":"80","author":"BJ Lipworth","year":"2025","unstructured":"Lipworth BJ, Greig R, Chan R, Kuo CR, Jackson C. Head-to-head comparison of biologic efficacy in asthma: what have we learned? Allergy. 2025;80(5):1226\u20131241. https:\/\/doi.org\/10.1111\/all.16537","journal-title":"Allergy"},{"issue":"8","key":"11100_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2023.100727","volume":"5","author":"LA D\u00edaz","year":"2023","unstructured":"D\u00edaz LA, Fuentes-L\u00f3pez E, Ayares G, et al. MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitis. JHEP Rep. 2023;5(8): 100727. https:\/\/doi.org\/10.1016\/j.jhepr.2023.100727","journal-title":"JHEP Rep"},{"key":"11100_CR38","doi-asserted-by":"publisher","unstructured":"MELD 3.0 in advanced chronic liver disease | Annual reviews. Accessed 22 Oct 2025. https:\/\/doi.org\/10.1146\/annurev-med-051322-122539","DOI":"10.1146\/annurev-med-051322-122539"},{"issue":"8","key":"11100_CR39","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/s41591-019-0508-1","volume":"25","author":"G Campanella","year":"2019","unstructured":"Campanella G, Hanna MG, Geneslaw L, et al. Clinical-grade computational pathology using weakly supervised deep learning on whole slide images. Nat Med. 2019;25(8):1301\u20131309. https:\/\/doi.org\/10.1038\/s41591-019-0508-1","journal-title":"Nat Med"},{"key":"11100_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2023.100984","author":"J Fan","year":"2024","unstructured":"Fan J, Fang L, Cong S, et al. Potential pre-COPD indicators in association with COPD development and COPD prediction models in Chinese: a prospective cohort study. Lancet Reg Health West Pac. 2024. https:\/\/doi.org\/10.1016\/j.lanwpc.2023.100984","journal-title":"Lancet Reg Health West Pac"},{"issue":"1","key":"11100_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46142-w","volume":"15","author":"A Kore","year":"2024","unstructured":"Kore A, Abbasi Bavil E, Subasri V, et al. Empirical data drift detection experiments on real-world medical imaging data. Nat Commun. 2024;15(1): 1887. https:\/\/doi.org\/10.1038\/s41467-024-46142-w","journal-title":"Nat Commun"},{"key":"11100_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.media.2020.101636","author":"F Guo","year":"2020","unstructured":"Guo F, Ng M, Goubran M, et al. Improving cardiac MRI convolutional neural network segmentation on small training datasets and dataset shift: a continuous kernel cut approach. Med Image Anal. 2020. https:\/\/doi.org\/10.1016\/j.media.2020.101636","journal-title":"Med Image Anal"},{"issue":"6","key":"11100_CR43","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.13685","volume":"8","author":"V Subasri","year":"2025","unstructured":"Subasri V, Krishnan A, Kore A, et al. Detecting and remediating harmful data shifts for the responsible deployment of clinical AI models. JAMA Netw Open. 2025;8(6): e2513685. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.13685","journal-title":"JAMA Netw Open"},{"key":"11100_CR44","unstructured":"Lundberg SM, Lee SI. A unified approach to interpreting model predictions. In: Advances in Neural Information Processing Systems. Vol 30. Curran Associates, Inc.; 2017. Accessed: 23 Oct 2025. https:\/\/papers.nips.cc\/paper\/2017\/hash\/8a20a8621978632d76c43dfd28b67767-Abstract.html"},{"issue":"10","key":"11100_CR45","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/s41551-018-0304-0","volume":"2","author":"SM Lundberg","year":"2018","unstructured":"Lundberg SM, Nair B, Vavilala MS, et al. Explainable machine-learning predictions for the prevention of hypoxaemia during surgery. Nat Biomed Eng. 2018;2(10):749\u2013760. https:\/\/doi.org\/10.1038\/s41551-018-0304-0","journal-title":"Nat Biomed Eng"},{"issue":"1","key":"11100_CR46","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s42256-019-0138-9","volume":"2","author":"SM Lundberg","year":"2020","unstructured":"Lundberg SM, Erion G, Chen H, et al. From local explanations to global understanding with explainable AI for trees. Nat Mach Intell. 2020;2(1):56\u201367. https:\/\/doi.org\/10.1038\/s42256-019-0138-9","journal-title":"Nat Mach Intell"},{"key":"11100_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2025.103849","volume":"86","author":"Y ShangGuan","year":"2025","unstructured":"ShangGuan Y, Lin Z, Wu K, Sim YJ, Xuan W. Comments on \u201cmachine learning and SHAP value interpretation for predicting comorbidity of cardiovascular disease and cancer with dietary antioxidants.\u201d Redox Biol. 2025;86: 103849. https:\/\/doi.org\/10.1016\/j.redox.2025.103849","journal-title":"Redox Biol"},{"key":"11100_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhazmat.2025.137382","volume":"488","author":"Y Takefuji","year":"2025","unstructured":"Takefuji Y. Beyond XGBoost and SHAP: unveiling true feature importance. J Hazard Mater. 2025;488: 137382. https:\/\/doi.org\/10.1016\/j.jhazmat.2025.137382","journal-title":"J Hazard Mater"},{"key":"11100_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103470","volume":"79","author":"X Qi","year":"2025","unstructured":"Qi X, Wang S, Fang C, Jia J, Lin L, Yuan T. Machine learning and SHAP value interpretation for predicting comorbidity of cardiovascular disease and cancer with dietary antioxidants. Redox Biol. 2025;79: 103470. https:\/\/doi.org\/10.1016\/j.redox.2024.103470","journal-title":"Redox Biol"},{"issue":"1","key":"11100_CR50","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1055\/s-0039-1678693","volume":"10","author":"J Wang","year":"2019","unstructured":"Wang J, Liang H, Kang H, Gong Y. Understanding health information technology induced medication safety events by two conceptual frameworks. Appl Clin Inform. 2019;10(1):158\u2013167. https:\/\/doi.org\/10.1055\/s-0039-1678693","journal-title":"Appl Clin Inform"},{"issue":"1","key":"11100_CR51","doi-asserted-by":"publisher","first-page":"e64","DOI":"10.1016\/S2589-7500(24)00224-3","volume":"7","author":"JE Alderman","year":"2025","unstructured":"Alderman JE, Palmer J, Laws E, et al. Tackling algorithmic bias and promoting transparency in health datasets: the STANDING together consensus recommendations. Lancet Digit Health. 2025;7(1):e64\u2013e88. https:\/\/doi.org\/10.1016\/S2589-7500(24)00224-3","journal-title":"Lancet Digit Health"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-026-11100-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-026-11100-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-026-11100-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T16:00:54Z","timestamp":1779465654000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-026-11100-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":51,"alternative-id":["11100"],"URL":"https:\/\/doi.org\/10.1007\/s12072-026-11100-9","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"9 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Yuli Song, Weixiao Shi, Chengchen Yang, Xiaochen Yang, and Chengbo Yu have no conflict of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}